Simon P. Joel - Concepedia

Author

Simon P. Joel

St Bartholomew's Hospital

Also Known As

Simon P Joel, Simon P. Joel, Simon P. Joel, PhD

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

St Bartholomew's Hospital Queen Mary University of London Cancer Research UK University College London Millennium Engineering and Integration (United States)

About

Simon P. Joel is an author at St Bartholomew's Hospital specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.4K
2	Health Sciences	4	4	89
3	Natural Sciences	4	4	114
4	Engineering	1	1	69
5	Allergy	1	1	39

Simon P. Joel

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Robert te Poele, Andrei L. Okorokov, Lesley Jardine, PubMed Lifespan ExtensionTumor BiologyGenome InstabilityWild-type P53Dna Damage	2002	646
Bortezomib Therapy in Patients With Relapsed or Refractory Lymphoma: Potential Correlation of In Vitro Sensitivity and Tumor Necrosis Factor Alpha Response With Clinical Activity Sandra J. Strauss, Lenushka Maharaj, Susan Hoare, Journal of Clinical Oncology	2006	171
The Proteasome Inhibitor Bortezomib Acts Independently of p53 and Induces Cell Death via Apoptosis and Mitotic Catastrophe in B-Cell Lymphoma Cell Lines Sandra J. Strauss, Karen Higginbottom, Simone Jüliger, Cancer Research Hematological MalignancyCell Cycle AnalysisMedicineInduces Cell DeathApoptosis	2007	112
The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers Elodie Noël, Marc Yeste‐Velasco, Xueying Mao, American Journal Of Pathology Cisplatin ResistanceMedicinePathologyCcnd1 OverexpressionCancer Biology	2010	102
Raman spectroscopic analysis of breast cancer tissues: identifying differences between normal, invasive ductal carcinoma and ductal carcinoma <i>in situ</i> of the breast tissue Shazza Rehman, Zanyar Movasaghi, Art Tucker, Journal of Raman Spectroscopy EngineeringBreast Cancer TissuesSurface-enhanced Raman ScatteringPathologySpectrochemical Analysis	2007	69
The bioavailability of morphine applied topically to cutaneous ulcers Maria DC Ribeiro, Simon P. Joel, Giovambattista Zeppetella Journal of Pain and Symptom Management MedicineLocal PharmacologyCutaneous UlcersTopical DrugSkin Pharmacology	2004	68
Limited Phase I Study of Morphine-3-Glucuronide Richard T. Penson, Simon P. Joel, Simon J. Clark, Journal of Pharmaceutical Sciences Medicinal ChemistryBiochemistryMedicineNatural SciencesLimited Phase	2001	59
RNA synthesis block by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells Robert te Poele, Andrei L. Okorokov, Simon P. Joel Oncogene Tumor BiologyOncologyP53-dependent ApoptosisMedicineApoptosis	1999	59
The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine‐6‐glucuronide Richard T. Penson, Simon P. Joel, Michael S. Roberts, British Journal of Clinical Pharmacology	2002	54
Phase I and Pharmacokinetic Study of Intravenous Irinotecan Plus Oral Ciclosporin in Patients With Fluorouracil-Refractory Metastatic Colon Cancer John Chester, Simon P. Joel, S L Cheeseman, Journal of Clinical Oncology	2003	48

Page 1